Team:EPF Lausanne/Calendar/15 August 2013

From 2013.igem.org

(Difference between revisions)
 
(One intermediate revision not shown)
Line 1: Line 1:
{{Template:EPFL2013Header}}
{{Template:EPFL2013Header}}
 +
<font size = "4"> Cell Surface Display </font> <BR>
 +
 +
''BBa_K523013 Characterisation'' <br>
 +
Characterisation of the iGEM plasmid BBa_K523013 we decided to use.
 +
<br><br>
<font size = "4"> Sensing-Effector </font> <BR>
<font size = "4"> Sensing-Effector </font> <BR>
''Primer Resuspension'' <BR>
''Primer Resuspension'' <BR>
-
-We recieved our primers and resuspended them. Then we dilluted them in order to have a final concentration of 100umol.
+
-We received our primers and resuspended them. Then we diluted them in order to have a final concentration of 100umol.
<BR>
<BR>
-
''Innoculating Bacteria'' <BR>
+
''Inoculating Bacteria'' <BR>
-
-From each agar plate that we inncubated over-night we innoculated one colony in order to make a glycerol stock of MMP2 and MMP9 containing bacteria the next day.  
+
-From each agar plate that we incubated over-night we inoculated one colony in order to make a glycerol stock of MMP2 and MMP9 containing bacteria the next day.  
<BR> <BR>
<BR> <BR>
Line 15: Line 20:
''Making Nanoparticles, 2nd try''
''Making Nanoparticles, 2nd try''
<BR>- The nanoparticles are done.
<BR>- The nanoparticles are done.
-
<BR>- Characterization of the new gelatin nanoparticles with the DLS : their average size is 160 nm !  
+
<BR>- Characterisation of the new gelatin nanoparticles with the DLS : their average size is 160 nm !  
{{Template:EPFL2013Footer}}
{{Template:EPFL2013Footer}}

Latest revision as of 21:51, 4 October 2013

Taxi.Coli: Smart Drug Delivery iGEM EPFL

Header

Cell Surface Display

BBa_K523013 Characterisation
Characterisation of the iGEM plasmid BBa_K523013 we decided to use.

Sensing-Effector

Primer Resuspension
-We received our primers and resuspended them. Then we diluted them in order to have a final concentration of 100umol.

Inoculating Bacteria
-From each agar plate that we incubated over-night we inoculated one colony in order to make a glycerol stock of MMP2 and MMP9 containing bacteria the next day.

Nanoparicles

Making Nanoparticles, 2nd try
- The nanoparticles are done.
- Characterisation of the new gelatin nanoparticles with the DLS : their average size is 160 nm !